Cargando…
PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN
| Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431197/ http://dx.doi.org/10.1097/01.HS9.0000850164.28901.b2 |
| _version_ | 1784779986185486336 |
|---|---|
| author | Pemmaraju, N. Martinelli, G. Todisco, E. Tarella, C. Montesinos, P. Lane, A. A. Erba, H. P. Sweet, K. L. Walter, R. B. Deconinck, E. Wang, E. S. Aribi, A. Ulrikson, M. L. Levy, M. Y. Lebon, D. Marconi, G. DeAngelo, D. J. Rizzieri, D. Konopleva, M. Sloss, C. M. Wang, J. Malcolm, K. A. Zweidler-McKay, P. A. Daver, N. G. |
| author_facet | Pemmaraju, N. Martinelli, G. Todisco, E. Tarella, C. Montesinos, P. Lane, A. A. Erba, H. P. Sweet, K. L. Walter, R. B. Deconinck, E. Wang, E. S. Aribi, A. Ulrikson, M. L. Levy, M. Y. Lebon, D. Marconi, G. DeAngelo, D. J. Rizzieri, D. Konopleva, M. Sloss, C. M. Wang, J. Malcolm, K. A. Zweidler-McKay, P. A. Daver, N. G. |
| author_sort | Pemmaraju, N. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9431197 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94311972022-08-31 PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN Pemmaraju, N. Martinelli, G. Todisco, E. Tarella, C. Montesinos, P. Lane, A. A. Erba, H. P. Sweet, K. L. Walter, R. B. Deconinck, E. Wang, E. S. Aribi, A. Ulrikson, M. L. Levy, M. Y. Lebon, D. Marconi, G. DeAngelo, D. J. Rizzieri, D. Konopleva, M. Sloss, C. M. Wang, J. Malcolm, K. A. Zweidler-McKay, P. A. Daver, N. G. Hemasphere Publication Only Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9431197/ http://dx.doi.org/10.1097/01.HS9.0000850164.28901.b2 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Publication Only Pemmaraju, N. Martinelli, G. Todisco, E. Tarella, C. Montesinos, P. Lane, A. A. Erba, H. P. Sweet, K. L. Walter, R. B. Deconinck, E. Wang, E. S. Aribi, A. Ulrikson, M. L. Levy, M. Y. Lebon, D. Marconi, G. DeAngelo, D. J. Rizzieri, D. Konopleva, M. Sloss, C. M. Wang, J. Malcolm, K. A. Zweidler-McKay, P. A. Daver, N. G. PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN |
| title | PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN |
| title_full | PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN |
| title_fullStr | PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN |
| title_full_unstemmed | PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN |
| title_short | PB1828: CADENZA: A PIVOTAL STUDY OF PIVEKIMAB SUNIRINE (IMGN632) IN PATIENTS WITH UNTREATED/FRONTLINE BPDCN |
| title_sort | pb1828: cadenza: a pivotal study of pivekimab sunirine (imgn632) in patients with untreated/frontline bpdcn |
| topic | Publication Only |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9431197/ http://dx.doi.org/10.1097/01.HS9.0000850164.28901.b2 |
| work_keys_str_mv | AT pemmarajun pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT martinellig pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT todiscoe pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT tarellac pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT montesinosp pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT laneaa pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT erbahp pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT sweetkl pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT walterrb pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT deconincke pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT wanges pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT aribia pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT ulriksonml pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT levymy pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT lebond pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT marconig pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT deangelodj pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT rizzierid pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT konoplevam pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT slosscm pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT wangj pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT malcolmka pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT zweidlermckaypa pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn AT daverng pb1828cadenzaapivotalstudyofpivekimabsunirineimgn632inpatientswithuntreatedfrontlinebpdcn |